Characterization of the restricted component of Epstein-Barr virus early antigens as a cytoplasmic filamentous protein
- 1 June 1986
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 58 (3) , 748-756
- https://doi.org/10.1128/jvi.58.3.748-756.1986
Abstract
Four monoclonal antibodies produced against the restricted component of the Epstein-Barr virus (EBV) early antigen (EA-R) precipitated a polypeptide with an approximate molecular weight of 85,000. Three of these antibodies prepared against the native 85,000-molecular-weight protein (85K protein) reacted by immunofluorescence with acetone-fixed smears but not methanol-fixed smears of EBV-producing cells activated with tumor-promoting agent and sodium butyrate. The fourth monoclonal antibody which was produced against the denatured 85K protein reacted with both acetone-fixed cells and methanol-fixed cells. Blocking of direct immunofluorescence by the different monoclonal antibodies established that these monoclonal antibodies were directed against three different epitopes expressed on the 85K protein. The cytoplasmic staining pattern produced by each antibody was granular during the first 24 to 28 h after induction, developed into filamentous structures about 36 h after induction, and then began to aggregate after 48 h. Similar structures were observed in human placental cells transfected by EBV DNA and stained with three of the monoclonal antibodies. These results suggest that the EA-R polypeptide is assembled into filaments during the EBV lytic cycle. The significance of this in regards to replication has yet to be determined. Biochemical characterization of this major EA-R component did not reveal any major differences in this protein isolated from different cell lines.This publication has 23 references indexed in Scilit:
- Expression of a nuclear and a cytoplasmic Epstein-Barr virus early antigen after DNA transfer: cooperation of two distant parts of the genome for expression of the cytoplasmic antigen.Proceedings of the National Academy of Sciences, 1984
- Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigenVirology, 1984
- A sensitive Enzyme-Linked Immunosorbent Assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigensJournal of Immunological Methods, 1984
- Functional mapping of the Epstein-Barr virus genome: Identification of sites coding for the restricted early antigen, the diffuse early antigen, and the nuclear antigenVirology, 1983
- Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments.Proceedings of the National Academy of Sciences, 1983
- Epstein-Barr Viral DNA: Infectivity for Human Placental CellsScience, 1981
- Radioimmune precipitation study comparing the epstein-barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA)Virology, 1980
- Epstein‐Barr virus‐induced membrane antigens: Immunochemical characterization of triton X‐100 solubilized viral membrane antigens from EBV‐superinfected raji cellsInternational Journal of Cancer, 1979
- Herpes Simplex Virus Types 1 and 2 in Clinical Infections: Differences Observed by Electron MicroscopyThe Journal of Infectious Diseases, 1977
- Demonstration of two distinct components in the early antigen complex of epstein‐barr virus‐infected cellsInternational Journal of Cancer, 1971